Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Problemy Endokrinologii|January 12, 2022
[The use of radioactive substances in medicine - history and development prospects]M S Sheremeta, A A Trukhin, M O KorchaginaProblemy Endokrinologii|October 2, 2019
[Radioiodine therapy for Graves' disease as a risk factor of endocrine ophthalmopathy]M S Sheremeta, I M Belovalova, N Y SviridenkoProblemy Endokrinologii|October 2, 2019
[Radioiodine therapy for Graves disease as a risk factor of endocrine ophthalmopathy]M S Sheremeta, I M Belovalova, N Y SviridenkoTerapevticheskii Arkhiv|December 21, 2020
[The prevalence of newly diagnosed autoimmune diseases among patients with Graves' disease and autoimmune polyglandular syndrome of adults]E A Troshina, A A Larina, M S Sheremeta, et al.Problemy Endokrinologii|March 16, 2025
[Female reproductive function after radioiodine therapy for differentiated thyroid carcinoma]M O Korchagina, E N Andreeva, M S Sheremeta, et al.Problemy Endokrinologii|September 27, 2025
[The History of the Development of Radioiodine Therapy in Russia]M S Sheremeta, M V Reinberg, K V Frolov, et al.Vestnik Oftalmologii|December 29, 2021
[Treatment of Graves' disease in patients with thyroid eye disease]N Yu Sviridenko, M S Sheremeta, I M Belovalova, et al.Terapevticheskii Arkhiv|December 5, 2022
[Radioactive iodine in the treatment of Graves' disease: history and modern concept of radionuclide therapy]M S Sheremeta, M O Korchagina, E D Pesheva, et al.Problemy Endokrinologii|June 2, 2026
[Changes in ovarian function and ovarian reserve after combined treatment for differentiated thyroid cancer]M O Korchagina, E N Andreeva, M S Sheremeta, et al.Problemy Endokrinologii|September 27, 2025
[Female reproductive function -after radioiodine therapy for differentiated thyroid carcinoma]M O Korchagina, E N Andreeva, A R Elfimova, et al.Pageof 3